Trial intelligence / Profile preview

Alendronate Sodium Vitamin D3 in Knee Osteoarthritis

NCT04739592Phase 4Unknown

Sponsor
Peking Union Medical College Hospital
Start
Jul 2021
Primary completion
Jul 2023
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of alendronate + cholecalciferol in knee osteoarthritis (OA), sponsored by Peking Union Medical College Hospital. Status: unknown.

02

Drugs

alendronate + cholecalciferol
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT04739592.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04739592.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call